As of 2025-11-05, the Relative Valuation of Veracyte Inc (VCYT) is 5.75 USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.12 USD, the upside of Veracyte Inc based on Relative Valuation is -84.1%.
The range of the Relative Valuation is 4.99 - 7.01 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 15.0x | 15.0x |
| Forward P/E multiples | 12.6x - 14.8x | 13.7x |
| Fair Price | 4.99 - 7.01 | 5.75 |
| Upside | -86.2% - -80.6% | -84.1% |
| Date | P/E |
| 2025-11-04 | 107.90 |
| 2025-11-03 | 108.89 |
| 2025-10-31 | 107.78 |
| 2025-10-30 | 105.54 |
| 2025-10-29 | 105.78 |
| 2025-10-28 | 106.35 |
| 2025-10-27 | 107.45 |
| 2025-10-24 | 109.72 |
| 2025-10-23 | 106.47 |
| 2025-10-22 | 103.81 |
| 2025-10-21 | 107.84 |
| 2025-10-20 | 109.48 |
| 2025-10-17 | 107.03 |
| 2025-10-16 | 106.97 |
| 2025-10-15 | 103.90 |
| 2025-10-14 | 101.42 |
| 2025-10-13 | 101.84 |
| 2025-10-10 | 103.96 |
| 2025-10-09 | 104.35 |
| 2025-10-08 | 104.85 |
| 2025-10-07 | 103.39 |
| 2025-10-06 | 107.66 |
| 2025-10-03 | 107.54 |
| 2025-10-02 | 106.44 |
| 2025-10-01 | 108.17 |
| 2025-09-30 | 102.55 |
| 2025-09-29 | 100.40 |
| 2025-09-26 | 99.89 |
| 2025-09-25 | 98.04 |
| 2025-09-24 | 97.62 |
| 2025-09-23 | 102.02 |
| 2025-09-22 | 101.36 |
| 2025-09-19 | 101.90 |
| 2025-09-18 | 99.27 |
| 2025-09-17 | 95.09 |
| 2025-09-16 | 96.43 |
| 2025-09-15 | 95.20 |
| 2025-09-12 | 92.25 |
| 2025-09-11 | 95.17 |
| 2025-09-10 | 92.07 |
| 2025-09-09 | 95.56 |
| 2025-09-08 | 96.97 |
| 2025-09-05 | 96.88 |
| 2025-09-04 | 94.16 |
| 2025-09-03 | 91.47 |
| 2025-09-02 | 89.95 |
| 2025-08-29 | 90.63 |
| 2025-08-28 | 89.47 |
| 2025-08-27 | 85.47 |
| 2025-08-26 | 86.84 |